Chicago (PRWEB) January 15, 2009
ClearTrial (http://www.cleartrial.com), a leading provider of clinical trial software for clinical trial operations planning, budgeting, and outsourcing, announced today that Deirdre BeVard, ClearTrial Vice President of Clinical Services, will speak at the CBI Forecasting & Budgeting conference at the Crowne Plaza Hotel in Philadelphia, February 3-4, 2009. BeVard will address the rapidly growing use of adaptive trial design in clinical development, focusing on helping life sciences companies address the unique challenges this approach poses for accurate forecasting, budgeting, and operational planning.
While promising significant benefits such as better safety and efficacy data and faster drug development with lower costs, adaptive clinical trials place a far greater burden on planning and initial trial design. Adaptive trials are challenging to forecast and budget since planners must create multiple and varied trial scenarios accounting for shifting resource allocations, timelines, treatment arms, and more. In addition, adaptive trials place a greater burden than traditional trials on certain areas such as biostatistics, data management, and project management.
Attendees of this session will discover:
-Common design principles of adaptive trials and their operational impact
-Practical guidelines for accurately forecasting and budgeting adaptive trials
-The importance of activity-based planning to successful adaptive trial forecasting and budgeting
-Critical operational success factors for initial adaptive trial design
BeVard offers 20 years of industry experience to conference attendees, with an extensive background in clinical trial planning. Prior to joining ClearTrial, she was Executive Director, Clinical Research for the Physician Alliance for Clinical Research (PACR), formerly part of HealthSouth. BeVard also served as Senior Director of Clinical Operations at Otsuka Maryland Research Institute, where she was responsible for the direction, strategy and execution of global clinical trial operations.
ClearTrial® is a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing. ClearTrial software helps pharmaceutical, biotechnology, medical device companies, and CROs expedite the clinical development process without sacrificing quality of results. The company's software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit http://www.cleartrial.com.
ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.